Idorsia
Hugo Perez has a range of work experience in various companies and roles. Hugo started their career as a Chemielaborant at Clariant in 1991 and worked there until 2003. Hugo then joined RCC Laboratories India Private Limited as a Reprotox Coordinator from 2004 to 2007. Hugo moved on to Actelion, where they held the positions of Non Clinical Study Coordinator from 2007 to 2010 and Systemadministrator IT Quality systems from 2010 to 2013. Currently, Hugo is with Idorsia Pharmaceuticals Ltd as the Associate Director Non Clinical Study Team Leader since 2019.
Hugo Perez completed a Diploma in Techniker HF Informatik from HF-ICT from 2000 to 2003. Prior to that, they studied Technische Berufs Maturität with a focus on Chemistry from 1988 to 1991. During the same period, they also attended laboratory technician SANDOZ, specializing in Chemistry.
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.